The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Medication-Assisted Therapies — Tackling the Opioid-Overdose Epidemic
Open accessAbstract
From the Institutes for Behavior Resources (Y.O.) and the Maryland Department of Health and Mental Hygiene (J.M.S.) -both in
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Pharmaceutical Overdose Deaths, United States, 2010
Jones, C. M., Mack, K. A., & Paulozzi, L. J. (2013) · JAMA · doi:10.1001/jama.2013.272 · Cited by 678
Opioid agonist treatments and heroin overdose deaths in Baltimore, Maryland, 1995–2009
Schwartz, R. P., Gryczynski, J., O’Grady, K. E., Sharfstein, J. M., Warren, G., Olsen, Y., Mitchell, S. G., & Jaffe, J. H. (2013) · American Journal of Public Health · doi:10.2105/ajph.2012.301049 · Cited by 276
Adoption and Implementation of Medications in Addiction Treatment Programs
Knudsen, H. K., Abraham, A. J., & Roman, P. M. (2011) · Journal of Addiction Medicine · doi:10.1097/adm.0b013e3181d41ddb · Cited by 210
Cited by
Rising morbidity and mortality in midlife among white non-Hispanic Americans in the 21st century
Case, A., & Deaton, A. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1518393112 · Cited by 2,759
Increases in drug and opioid overdose deaths — United States, 2000–2014
Rudd, R. A., Aleshire, N., Zibbell, J. E., & Gladden, R. M. (2016) · MMWR Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm6450a3 · Cited by 1,859
The Prescription Opioid and Heroin Crisis: A Public Health Approach to an Epidemic of Addiction
Kolodny, A., Courtwright, D. T., Hwang, C. S., Kreiner, P., Eadie, J. L., Clark, T. W., & Alexander, G. C. (2015) · Annual Review of Public Health · doi:10.1146/annurev-publhealth-031914-122957 · Cited by 1,388
“Despite strong evidence supporting the use of buprenorphine and methadone, fewer than 1 million Americans are receiving these treatments (87).”
Larochelle, M. R., Bernson, D., Land, T., Stopka, T. J., Wang, N., Xuan, Z., Bagley, S. M., Liebschutz, J. M., & Walley, A. Y. (2018) · Annals of Internal Medicine · doi:10.7326/m17-3107 · Cited by 1,076
“Some efforts to address this crisis focus on expanding access to effective treatment of opioid use disorders (OUDs) (2).”
BackgroundRelationship between Nonmedical Prescription-Opioid Use and Heroin Use
Compton, W. M., Jones, C. M., & Baldwin, G. T. (2016) · New England Journal of Medicine · doi:10.1056/nejmra1508490 · Cited by 1,044
Kourtis, A. P., Hatfield, K., Baggs, J., Mu, Y., See, I., Epson, E., Nadle, J., Kainer, M. A., Dumyati, G., Petit, S., et al. (2019) · MMWR. Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm6809e1 · Cited by 701
“Prevention of opioid misuse, increasing access and linkage to medicationassisted treatment for persons with opioid use disorder (27), ensuring access to sterile injecting equipment, improving education about safer injection practices and how to recognize early signs of infection, and linking those with an infection to…”
BackgroundThe triple wave epidemic: Supply and demand drivers of the US opioid overdose crisis
Ciccarone, D. (2019) · International Journal of Drug Policy · doi:10.1016/j.drugpo.2019.01.010 · Cited by 677
National and state treatment need and capacity for opioid agonist medication-assisted treatment
Jones, C. M., Campopiano, M., Baldwin, G., & McCance-Katz, E. (2015) · American Journal of Public Health · doi:10.2105/ajph.2015.302664 · Cited by 668
Medication-Assisted Treatment of Opioid Use Disorder: Review of the Evidence and Future Directions
Connery, H. S. (2015) · Harvard Review of Psychiatry · doi:10.1097/hrp.0000000000000075 · Cited by 576
The Role of Science in Addressing the Opioid Crisis
Volkow, N. D., & Collins, F. S. (2017) · New England Journal of Medicine · doi:10.1056/nejmsr1706626 · Cited by 555
Self-citationA review: Fentanyl and non-pharmaceutical fentanyls
Suzuki, J., & El-Haddad, S. (2017) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2016.11.033 · Cited by 445
Ma, J., Bao, Y.-P., Wang, R.-J., Su, M.-F., Liu, M.-X., Li, J.-Q., Degenhardt, L., Farrell, M., Blow, F. C., Ilgen, M., et al. (2019) · Molecular Psychiatry · doi:10.1038/s41380-018-0094-5 · Cited by 396
Han, B., Compton, W. M., Jones, C. M., & Cai, R. (2015) · JAMA · doi:10.1001/jama.2015.11859 · Cited by 366
Opioid Use and Storage Patterns by Patients after Hospital Discharge following Surgery
Bartels, K., Mayes, L. M., Dingmann, C., Bullard, K. J., Hopfer, C. J., & Binswanger, I. A. (2016) · PLOS ONE · doi:10.1371/journal.pone.0147972 · Cited by 362
Increases in Drug and Opioid Overdose Deaths—United States, 2000–2014
Rudd, R. A., Aleshire, N., Zibbell, J. E., & Matthew Gladden, R. (2016) · American Journal of Transplantation · doi:10.1111/ajt.13776 · Cited by 351
Do medical marijuana laws reduce addictions and deaths related to pain killers?
Powell, D., Pacula, R. L., & Jacobson, M. (2018) · Journal of Health Economics · doi:10.1016/j.jhealeco.2017.12.007 · Cited by 345
Treatment utilization among persons with opioid use disorder in the United States
Wu, L.-T., Zhu, H., & Swartz, M. S. (2016) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2016.10.015 · Cited by 340
Development of a Cascade of Care for responding to the opioid epidemic.
Williams, A. R., Nunes, E. V., Bisaga, A., Levin, F. R., & Olfson, M. (2019) · The American Journal of Drug and Alcohol Abuse · doi:10.1080/00952990.2018.1546862 · Cited by 332
Morgan, J. R., Schackman, B. R., Leff, J. A., Linas, B. P., & Walley, A. Y. (2018) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2017.07.001 · Cited by 332
Understanding Links among Opioid Use, Overdose, and Suicide
Bohnert, A. S. B., & Ilgen, M. A. (2019) · New England Journal of Medicine · doi:10.1056/nejmra1802148 · Cited by 317
Macroeconomic conditions and opioid abuse
Hollingsworth, A., Ruhm, C. J., & Simon, K. (2017) · Journal of Health Economics · doi:10.1016/j.jhealeco.2017.07.009 · Cited by 312
Winkelman, T. N. A., Chang, V. W., & Binswanger, I. A. (2018) · JAMA Network Open · doi:10.1001/jamanetworkopen.2018.0558 · Cited by 301
Patrick, S. W., Fry, C. E., Jones, T. F., & Buntin, M. B. (2016) · Health Affairs · doi:10.1377/hlthaff.2015.1496 · Cited by 299
Bhattacharya, D., Aronsohn, A., Price, J., Lo Re, V., the American Association for the Study of Liver Diseases–Infectious Diseases Society of America HCV Guidance Panel, Heald, J., Demisashi, G., Durzy, E., Davis-Owino, A., & Tynes, S. (2023) · Clinical Infectious Diseases · doi:10.1093/cid/ciad319 · Cited by 296
Opioid-related mortality in rural America: Geographic heterogeneity and intervention strategies
Rigg, K. K., Monnat, S. M., & Chavez, M. N. (2018) · International Journal of Drug Policy · doi:10.1016/j.drugpo.2018.04.011 · Cited by 294
Why aren't physicians prescribing more buprenorphine?
Huhn, A. S., & Dunn, K. E. (2017) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2017.04.005 · Cited by 291
Today’s fentanyl crisis: Prohibition’s Iron Law, revisited
Beletsky, L., & Davis, C. S. (2017) · International Journal of Drug Policy · doi:10.1016/j.drugpo.2017.05.050 · Cited by 283
Dowell, D., Zhang, K., Noonan, R. K., & Hockenberry, J. M. (2016) · Health Affairs · doi:10.1377/hlthaff.2016.0448 · Cited by 264
Haegerich, T. M., Paulozzi, L. J., Manns, B. J., & Jones, C. M. (2014) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2014.10.001 · Cited by 272
Lofwall, M. R., Walsh, S. L., Nunes, E. V., Bailey, G. L., Sigmon, S. C., Kampman, K. M., Frost, M., Tiberg, F., Linden, M., Sheldon, B., et al. (2018) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2018.1052 · Cited by 255
Tanum, L., Solli, K. K., Latif, Z.-E.-H., Benth, J. Š., Opheim, A., Sharma-Haase, K., Krajci, P., & Kunøe, N. (2017) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2017.3206 · Cited by 253
Lister, J. J., Weaver, A., Ellis, J. D., Himle, J. A., & Ledgerwood, D. M. (2020) · The American Journal of Drug and Alcohol Abuse · doi:10.1080/00952990.2019.1694536 · Cited by 253
Krawczyk, N., Mojtabai, R., Stuart, E. A., Fingerhood, M., Agus, D., Lyons, B. C., Weiner, J. P., & Saloner, B. (2020) · Addiction · doi:10.1111/add.14991 · Cited by 177
Morgan, J. R., Schackman, B. R., Weinstein, Z. M., Walley, A. Y., & Linas, B. P. (2019) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2019.02.031 · Cited by 159
Geographic variation in opioid and heroin involved drug poisoning mortality rates
Ruhm, C. J. (2017) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2017.06.009 · Cited by 152
Substance use in rural Central Appalachia: Current status and treatment considerations.
Moody, L. N., Satterwhite, E., & Bickel, W. K. (2017) · Journal of Rural Mental Health · doi:10.1037/rmh0000064 · Cited by 155
Ketamine and Beyond: Investigations into the Potential of Glutamatergic Agents to Treat Depression
Lener, M. S., Kadriu, B., & Zarate, C. A. (2017) · Drugs · doi:10.1007/s40265-017-0702-8 · Cited by 131
“Furthermore, given that ketamine is considered an illicit substance in USA, a higher level of scrutiny must be considered, and large long-term follow-up studies are needed to definitively assess possible associations between ketamine use and issues of abuse and/ or dependence [83, 84].”
The Next Stage of Buprenorphine Care for Opioid Use Disorder
Martin, S. A., Chiodo, L. M., Bosse, J. D., & Wilson, A. (2018) · Annals of Internal Medicine · doi:10.7326/m18-1652 · Cited by 130
Alcohol, Cannabis, and Opioid Use Disorders, and Disease Burden in an Integrated Health Care System
Bahorik, A. L., Satre, D. D., Kline-Simon, A. H., Weisner, C. M., & Campbell, C. I. (2017) · Journal of Addiction Medicine · doi:10.1097/adm.0000000000000260 · Cited by 126
“…outcomes in those with opioid use disorders, yet the elevated risk of early mortality is largely attributable to opioid-related overdose deaths (Volkow et al., 2014), increasing nearly fourfold from 1999 to 2013, and claiming about 44 lives per day by 2013 (Centers for Disease Control, 2015).”
BackgroundInfluentialReducing the harm of opioid overdose with the safe use of naloxone: a pharmacologic review
Kim, H. K., & Nelson, L. S. (2015) · Expert Opinion on Drug Safety · doi:10.1517/14740338.2015.1037274 · Cited by 116
Garland, E. L., Hanley, A. W., Kline, A., & Cooperman, N. A. (2019) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2019.07.007 · Cited by 105
Pain as a Predictor of Opioid Use Disorder in a Nationally Representative Sample
Blanco, C., Wall, M. M., Okuda, M., Wang, S., Iza, M., & Olfson, M. (2016) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2016.15091179 · Cited by 81
Patterns and Quality of Buprenorphine Opioid Agonist Treatment in a Large Medicaid Program
Gordon, A. J., Lo-Ciganic, W.-H., Cochran, G., Gellad, W. F., Cathers, T., Kelley, D., & Donohue, J. M. (2015) · Journal of Addiction Medicine · doi:10.1097/adm.0000000000000164 · Cited by 76
Bornebusch, A. B., Fink-Jensen, A., Wörtwein, G., Seeley, R. J., & Thomsen, M. (2019) · eneuro · doi:10.1523/eneuro.0443-18.2019 · Cited by 72
Uyei, J., Fiellin, D. A., Buchelli, M., Rodriguez-Santana, R., & Braithwaite, R. S. (2017) · The Lancet Public Health · doi:10.1016/s2468-2667(17)30006-3 · Cited by 55
Barocas, J. A., Morgan, J. R., Wang, J., McLoone, D., Wurcel, A., & Stein, M. D. (2021) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa062 · Cited by 48
Cooperman, N. A., Lu, S.-E., Hanley, A. W., Puvananayagam, T., Dooley-Budsock, P., Kline, A., & Garland, E. L. (2024) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2023.5138 · Cited by 44
Huhn, A. S., Tompkins, D. A., & Dunn, K. E. (2017) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2017.08.019 · Cited by 45
“Although academic researchers and public health officials have advocated that OUD be treated with MAT (Volkow et al., 2014; Blum et al., 2016), the current study suggests Drug Alcohol Depend.”
BackgroundBuprenorphine treatment formulations: Preferences among persons in opioid withdrawal management
Kenney, S. R., Anderson, B. J., Bailey, G. L., & Stein, M. D. (2018) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2018.08.011 · Cited by 40
Correlates of specialty substance use treatment among adults with opioid use disorders
Romo, E., Ulbricht, C. M., Clark, R. E., & Lapane, K. L. (2018) · Addictive Behaviors · doi:10.1016/j.addbeh.2018.03.012 · Cited by 30
Feingold, D., Brill, S., Goor-Aryeh, I., Delayahu, Y., & Lev-Ran, S. (2017) · General Hospital Psychiatry · doi:10.1016/j.genhosppsych.2017.04.006 · Cited by 24
Skin-cleaning among hospitalized people who inject drugs: a randomized controlled trial
Stein, M. D., Phillips, K. T., Herman, D. S., Keosaian, J., Stewart, C., Anderson, B. J., Weinstein, Z., & Liebschutz, J. (2021) · Addiction · doi:10.1111/add.15236 · Cited by 23
Zhang, K., Jones, C. M., Compton, W. M., Guy, G. P., Evans, M. E., & Volkow, N. D. (2022) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.21m14001 · Cited by 22
Self-citationLu, Q., Zou, X., Liu, Y., Gong, C., & Ling, L. (2019) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph16152800 · Cited by 13
Media Exposure and Substance Use Increase during COVID-19
Amram, O., Borah, P., Kubsad, D., & McPherson, S. M. (2021) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph18126318 · Cited by 11
Carrà, G., Bartoli, F., Galanter, M., & Crocamo, C. (2019) · Postgraduate Medicine · doi:10.1080/00325481.2019.1546533 · Cited by 9
“Along with strategies regulating relevant medication-assisted therapies [43], our study supports the need for change in service delivery, with an integrated care model for both prevention and treatment [44].”
MethodHow Academic Medicine Can Help Confront the Opioid Crisis
Volkow, N. D., McLellan, T., & Blanco, C. (2022) · Academic Medicine · doi:10.1097/acm.0000000000004289 · Cited by 5
Self-citationCommonly Used Opioids in the Orthopedic Operating Room: A Narrative Review
Nguyen, A., Donnelly, J., Robinson, C. L., & Hasoon, J. (2026) · Orthopedic Reviews · doi:10.52965/001c.158576 · Cited by 3
The Logic and Practice of the Prevention of Mental Disorders
Mendelson, T., Pas, E. T., Lee-Winn, A. E., Bradshaw, C. P., Rebok, G. W., Leis, J. A., & Mandell, W. (2019) · Public Mental Health · doi:10.1093/oso/9780190916602.003.0019
Metadata
- Authors
- Volkow, N. D., Frieden, T. R., Hyde, P. S., & Cha, S. S.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2014-05-29
- Volume
- 370
- Issue
- 22
- Pages
- 2063-2066
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2025376268
- Cited by
- 1,015
- References
- 3
- FWCI
- 87.32
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.